Original Research

Meet the JCOM Author with Dr. Barkoudah: IVIG in Treating Nonventilated COVID-19 Patients With Moderate-to-Severe Hypoxia

Intravenous Immunoglobulin in Treating Nonventilated COVID-19 Patients With Moderate-to-Severe Hypoxia: A Pharmacoeconomic Analysis | JCOM Author Discussion

Dr. George Sakoulas is joined by Dr. Barkoudah to discuss his article published in the May/June 2022 issue of JCOM. His article reports on a study that demonstrates that despite high acquisition costs, IVIG is not only favorable pharmacoeconomically, but also can help preserve scarce critical care resources during COVID-19 pandemic waves when targeted to the appropriate patient population.


 

Vidyard Video

Next Article: